Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
Thierry Le Chevalier, Giorgio V. Scagliotti, Ronald B. Natale et al. · Lung Cancer · 2004
Cited by 277 works. doi:10.1016/j.lungcan.2004.10.014
Authors
- Thierry Le Chevalier
- Giorgio V. Scagliotti
- Ronald B. Natale
- Sarah J. Danson
- Rafael Rosell
- Rolf Arno Stahel
- P. A. Thomas
- Robin Rudd
- Johan Vansteenkiste
- N. Thatcher
- Ch. Manegold
- J-L. Pujol
- Nico van Zandwijk
- Cesare Gridelli
- Jan P. van Meerbeeck
- Lucio Crinò
- Michael Aristides
- Joan H. Schiller
References
- Meta-analysis in clinical trials
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
- Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
- Systematic Reviews in Health Care : Meta-Analysis in Context
- COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Polychemotherapy for early breast cancer: an overview of the randomised trials
- Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials